Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Lad

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Cancer|July 15, 1983
Taste thresholds of patients with cancer of the esophagusS Kamath, P Booth, T E Lad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studiesH Minami, T E Lad, M K Nicholas, et al.
Clinical Chemistry|September 1, 1981
Evaluation of routine ionized calcium determination in cancer patientsW P Shemerdiak, S C Kukreja, T E Lad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancerS G Taylor, W P McGuire, W W Hauck, et al.
Cancer Treatment Reports|March 1, 1987
Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neckM A Cobleigh, J H Hill, T E Lad, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 1, 1984
Nephrogenous cyclic adenosine monophosphate levels in normocalcemic cancer patients: its significanceE C Abramson, S C Kukreja, T E Lad, et al.
Calcified Tissue International|September 1, 1984
A model for malignancy-associated humoral hypercalcemiaE C Abramson, L J Kukla, D H Shevrin, et al.
Archives of Internal Medicine|February 1, 1987
Treatment of cancer-associated hypercalcemia with cisplatinT E Lad, H M Mishoulam, D H Shevrin, et al.
Clinical Pharmacy|March 1, 1985
Treatment of cancer-associated hypercalcemia with mithramycin and oral etidronate disodiumD H Shevrin, L R Bressler, W P McGuire, et al.
Investigational New Drugs|July 1, 1989
Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council StudyT E Lad, R R Blough, M Evrard, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Cancer|July 15, 1983
Taste thresholds of patients with cancer of the esophagusS Kamath, P Booth, T E Lad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studiesH Minami, T E Lad, M K Nicholas, et al.
Clinical Chemistry|September 1, 1981
Evaluation of routine ionized calcium determination in cancer patientsW P Shemerdiak, S C Kukreja, T E Lad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancerS G Taylor, W P McGuire, W W Hauck, et al.
Cancer Treatment Reports|March 1, 1987
Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neckM A Cobleigh, J H Hill, T E Lad, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 1, 1984
Nephrogenous cyclic adenosine monophosphate levels in normocalcemic cancer patients: its significanceE C Abramson, S C Kukreja, T E Lad, et al.
Calcified Tissue International|September 1, 1984
A model for malignancy-associated humoral hypercalcemiaE C Abramson, L J Kukla, D H Shevrin, et al.
Archives of Internal Medicine|February 1, 1987
Treatment of cancer-associated hypercalcemia with cisplatinT E Lad, H M Mishoulam, D H Shevrin, et al.
Clinical Pharmacy|March 1, 1985
Treatment of cancer-associated hypercalcemia with mithramycin and oral etidronate disodiumD H Shevrin, L R Bressler, W P McGuire, et al.
Investigational New Drugs|July 1, 1989
Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council StudyT E Lad, R R Blough, M Evrard, et al.
Pageof 4